Anzemet

Active Ingredient(s): Dolasetron
FDA Approved: * September 11, 1997
Pharm Company: * SANOFI AVENTIS US
Category: Nausea & Vomiting

Dolasetron (trade name Anzemet) is a serotonin 5-HT3 receptor antagonist used to treat nausea and vomiting following chemotherapy.[1] Its main effect is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medulla oblongata. It does not have much antiemetic effect when symptoms are due to motion sickness. This drug does not have any effect on dopamine receptors or muscarinic receptors. Dolasetron breaks down slowly, staying in t... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
4 Discussions

Dosage List

Anzemet A;50
Anzemet 50 mg Oral Tablet
NDC: 0088-1202
Labeler:
Sanofi-aventis U.S. LLC
Anzemet 100;ANZEMET
Anzemet 100 mg Oral Tablet
NDC: 0088-1203
Labeler:
Sanofi-aventis U.S. LLC
Anzemet A;50
Anzemet 50 mg Oral Tablet, Film Coated
NDC: 30698-120
Labeler:
Validus Pharmaceuticals LLC
Anzemet 100;ANZEMET
Anzemet 100 mg Oral Tablet, Film Coated
NDC: 30698-121
Labeler:
Validus Pharmaceuticals LLC
Anzemet 100;ANZEMET
Anzemet 100 mg Oral Tablet, Film Coated
NDC: 69189-0679
Labeler:
Avera Mckennan Hospital
Anzemet 100 mg/5ml Intravenous Injection
NDC: 0088-1206
Labeler:
Sanofi-aventis U.S. LLC
Anzemet 12.5 mg/.625ml Intravenous Injection
NDC: 0088-1208
Labeler:
Sanofi-aventis U.S. LLC
Anzemet 500 mg/25ml Intravenous Injection
NDC: 0088-1209
Labeler:
Sanofi-aventis U.S. LLC
Anzemet 50 mg Oral Tablet, Film Coated
NDC: 30698-220
Labeler:
Validus Pharmaceuticals LLC